Shares of Rapid Micro Biosystems, Inc. (RPID) are up by 13.76% at $1.24 in premarket trading Wednesday, following the release of its preliminary unaudited financial results for the fourth quarter and full year 2024.
For the fourth quarter of 2024, the company expects total revenue to be approximately $8.2 million, a 30% growth year-over-year, and slightly above Wall Street analysts' consensus estimate of $7.6 million.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com